Sat.Apr 17, 2021 - Fri.Apr 23, 2021

Lilly to seek first approval of an autoimmune drug for hair loss

Bio Pharma Dive

Two Phase 3 trials have now shown that Lilly's autoimmune drug baricitinib may effectively treat alopecia areata. But the FDA's concerns with so-called JAK inhibitors could complicate a review

Trials 248

Congratulations Manny Award winners

World of DTC Marketing

QUICK READ: The MedAd News Manny Awards were last night. Congratulations to the winners, but the bar has been set higher if pharma is to really demonstrate they care about patients. Award winners should see their awards as a head nod and understand they have a LOT more work to do.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Development of Oncology Therapies – Tips from the FDA to Drive Success

Camargo

Cancer is not a single disease, but rather hundreds of different diseases. Thus, there will never be a single cure to cancer.

Learning about system stability from ants

Scienmag

Coronavirus vaccine makers Oxford, Novavax follow up with a promising malaria shot

Bio Pharma Dive

A vaccine co-developed by the U.K. academic center and the Maryland biotech could be the first to meet the WHO's efficacy target for a malaria vaccine

The clock is ticking on healthcare’s excessive profiteering

World of DTC Marketing

QUICK READ: There is so much money in healthcare that every company wants their share even if patients get hurt. The amount of money Pfizer is going to make from their vaccine borders on obscene while PBMs quietly take a cut of every Rx transaction without really adding any value.

University of Oxford-Novavax Malaria Vaccine Demonstrates 77% Efficacy in Children

BioSpace

The same group at the University of Oxford and the Jenner Institute that developed the AstraZeneca-Oxford COVID-19 vaccine reported that their investigational malaria vaccine, R21/Matrix-M, demonstrated 77% efficacy in children over 12 months of follow-up

More Trending

Bluebird to withdraw gene therapy from Germany after dispute over price

Bio Pharma Dive

The biotech will cut staff, primarily in Europe, after negotiations with German health authorities resulted in a price lower than Bluebird had sought

The danger of COVID conspiracy theorists

World of DTC Marketing

QUICK READ: At times, the public health response to coronavirus (COVID-19) has been scary, characterized by antimask behavior, antivaccine beliefs, conspiracy theories around the development of the vaccine, and a general belief that even COVID numbers are false.

UK Vaccine Taskforce head lifts lid on Novavax deal

Pharma Phorum

The UK’s unique offering as a life sciences research hub helped convince US biotech Novavax to develop its COVID-19 jab there, according to the head of the country’s Vaccines Taskforce. .

Targeting drug-resistant breast cancer with estrogen

Scienmag

Dartmouth researchers achieve better long-term control of drug-resistant breast cancer growth in mice by switching between estrogen and anti-estrogen therapies.

The next 2 months in biotech and pharma will be busy. Here's what to watch.

Bio Pharma Dive

New developments could come soon for two coronavirus vaccines while, a bit further off, the fate of Biogen's Alzheimer's drug hangs in the balance. Important data are expected, too, for Vertex and Sarepta

DTC marketing is an oxymoron

World of DTC Marketing

QUICK READ: More TV DTC spots are airing, but DTC marketers are losing the battle between awareness and conversion because of all the noise online. Product websites are stagnant, and online health seekers are going elsewhere to learn about your medication’s side effects and cost.

CEO Salaries for the Top 20 Pharma Companies by Market Cap

BioSpace

Executives at pharmaceutical companies are known for receiving large salaries.

Energy unleashed by submarine volcanoes could power a continent

Scienmag

Credit: Image courtesy of the National Oceanic and Atmospheric Administration Volcanic eruptions deep in our oceans are capable of extremely powerful releases of energy, at a rate high enough to power the whole of the United States, according to research published today.

Positive data in hand, TG Therapeutics readies MS drug for FDA review

Bio Pharma Dive

If approved, TG's drug would join Roche's fast-selling Ocrevus and Novartis' newer entrant Kesimpta as one of a newer class of multiple sclerosis therapies

Drugs 232

Pharma Tuesday Stuff

World of DTC Marketing

QUICK READ: Here are some recent stories that you should all be aware of. Last month I hit 80,000 readers when accounting for email, social media, and direct traffic. I love the industry, and although I want to see some changes, I know there are many good people trying every day to make it happen.

Canine cancer research startup impacts treatment in humans

Outsourcing Pharma

One Healthâs FidoCure is using genomics and AI technology to develop precision oncological treatments, and the work is benefiting human cancer research. Clinical Development

Lighting it up: Fast material manipulation through a laser

Scienmag

Credit: © Beaulieu Making the speed of electronic technology as fast as possible is a central aim of contemporary materials research.

A startup raises $336M to make a better antibody drug for COVID-19

Bio Pharma Dive

Adagio Therapeutics, a well-financed spinout of antibody developer Adimab, could challenge Regeneron and Eli Lilly if its drug candidate proves protective in clinical tests

AI is having a productive time in pharma and healthcare

Pharma Phorum

Two years ago the use of AI in pharma and healthcare looked to be quickly heading for what Gartner’s Hype Cycle model would term the Plateau of Productivity.

Pfizer-BioNTech, Moderna Vaccines Effective Against Variants and More COVID-19 News

BioSpace

With the U.S. Food and Drug Administration’s vaccines advisory committee meeting being held today to discuss the Johnson & Johnson vaccine and blood clotting, there’s even more interest in what’s going on in the pandemic than usual. Here’s a look at some of the top stories

Drugs 91

A lesson from Arctic sea-ice prediction in 2020: accurate subseasonal-to-seasonal prediction remains a grand challenge

Scienmag

Credit: Photograph courtesy of the MABEL team; Plots by Ke Wei As an indicator and “amplifier” of global climate change, the Arctic’s health and stability is the cornerstone of the stability of our climate system.

66

Vertex bets another $900M on CRISPR treatment for blood diseases

Bio Pharma Dive

Vertex and CRISPR Therapeutics are tweaking their partnership so that the larger biotech will cover 60% of the costs — and receive 60% of the future profits — related to a gene editing therapy for sickle cell disease and beta thalassemia

New advice on COVID-19 vaccination for pregnant women in UK

Pharma Times

JCVI advises pregnant women in the UK be offered COVID-19 vaccination at the same time as the rest of the population

Tips for Demonstrating Leadership Skills on Your Resume

BioSpace

Regardless of the field that you work in, incorporating leadership skills on your resume is a crucial step in making sure your application is noticed by employers

91

Flexible diet may help leaf-eating lemurs resist deforestation

Scienmag

Digestive genes and anatomy are adapted to tough leaves, fruit and even pine needles Credit: Lydia Greene, Duke University DURHAM, N.C. – Fruits and veggies are good for you and if you are a lemur, they may even help mitigate the effects of habitat loss.

A look ahead at the FDA meeting that could decide the future of 6 cancer drug approvals

Bio Pharma Dive

Six accelerated approvals for immunotherapies from Merck, Bristol Myers Squibb and Roche might soon be withdrawn. Here's a detailed look at why

Drugs 181

Novo Nordisk plans study of oral semaglutide in obesity

Pharma Times

Study will include approximately 1,000 people with obesity or overweight with comorbidities

87

Antibody Structure: All You Ever Wanted – and Needed – to Know

BioSpace

Simply put, an antibody is a large, Y-shaped blood protein produced by plasma cells that the immune system uses to take down pathogens like bacteria – and of course, viruses like SARS-CoV-2

Army-funded research paves way for improved lasers, communications

Scienmag

Credit: Courtesy University of Pennsylvania RESEARCH TRIANGLE PARK, N.C. — New photonics research paves the way for improved lasers, high-speed computing and optical communications for the Army.

With money pouring into biotech, Versant raises another $950M

Bio Pharma Dive

Versant's announcement comes as biotechs continue to rake in record levels of cash, supporting a wave of new drug company startups

Drugs 181

Looking ahead: Israel sets up 2022 COVID-19 vaccine supply with Pfizer and Moderna

BioPharma Reporter

Israel has set up COVID-19 vaccine orders with Pfizer and Moderna this week: marking deals over the longer term for the two companies. Markets & Regulations

Humanigen’s Cytokine Storm Control Drug Shows Positive Results in CAR-T Trial

BioSpace

Humanigen reported positive data from its Phase Ib ZUMA-19 trial of lenzilumab in patients treated with CAR-T in diffuse large B-cell lymphoma (DLBCL

Researchers identify predictive factors of delirium in Sub-Saharan Africa

Scienmag

Credit: Vanderbilt University Medical Center Severity of illness, history of stroke, and being divorced or widowed were independently predictive of delirium in hospitalized patients in Zambia, according to a study published in PLOS ONE.

CDC advisers recommend resuming use of J&J vaccine

Bio Pharma Dive

While health officials have documented more cases of a rare blood clotting syndrome associated with J&J's vaccine, a CDC committee supported use of the shot with an added warning

NICE says yes to Novartis’ multiple sclerosis therapy Kesimpta

Pharma Phorum

Novartis has secured backing from NICE for its relapsing multiple sclerosis (RMS) therapy Kesimpta in the UK, just two weeks after the drug was approved by the national drugs regulator. .

Sales 87